Shandong Chenghui Shuangda Pharmaceutical

About Shandong Chenghui Shuangda Pharmaceutical

Shandong Chenghui Shuangda Pharmaceutical Co., Ltd. specializes in R&D and production of APIs and advanced intermediates , CDMO/CRO/OEM, and Technology Transfer of Finished Formulations. With 23 years of production experience, the company&nb...

Certifications
  • Country/Region:
    China
  • On CPHI since:
    2023
  • Certificates:
    4
  • Employees:
    500 - 999
Company types
CMO/CDMO
Manufacturer/Innovator
Pharmaceutical company
Veterinary Company
Primary activities
Animal Health
API Producer
Contract Research Organisation
Generic APIs producer
Intermediates Manufacturer
Contact info

Products from Shandong Chenghui Shuangda Pharmaceutical (3)

  • Dapagliflozin

    Product Dapagliflozin

    Product name:  Dapagliflozin propanediol monohydrateSynonyms: (2S,3R,4R,5S,6R)-2-(4-CHLORO-3-(4-ETHOXYBENZYL)PHENYL)-6-(HYDROXYMETHYL)TETRAHYDRO-2H-PYRAN-3,4,5-TRIOLCOMPOUNDWITH(S)-POPANE-1,2,3,4,5-(HYDROXYMETHYL)TETRAHYDRO PROPANE-1,2-DIOL(1:1)HYDRATE;BMS512148(2S)-1,2-propanediol;CS-1307;Dapaglifloz...
  • Finerenone

    Product Finerenone

    Product name: Finerenone
    Alias: Finerenone (BAY94-8862); (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide; (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide; BAY94-8862; BAY948862; 1,6-Naphthyridine-3-...
  • Letermovir

    Product Letermovir


    Product name: Letermovir

    alias: Letemovir; Lemovir; Letemovir; (S)-2-(8-fluoro-3-(2-methoxy-5-(trifluoromethyl)phenyl)-2-(4-(3-methoxyphenyl)piperazin-1-yl)-3,4-dihydroquinazolin-4-yl)acetic acid; Letemovir Standard 005; Letemovir; Letemovir-letemovir; Letemovir-letemovir Letermovir
    ...

Shandong Chenghui Shuangda Pharmaceutical Resources (2)

  • News Tetracaine HCl API Granted CEP by EDQM

    We are proud to announce that our pharmaceutical ingredient Tetracaine Hydrochloride has been granted the Certificate of Suitability to the European Pharmacopoeia (CEP) by the European Directorate for the Quality of Medicines (EDQM) on August 20, 2025. This marks a significant milestone as we become the first company in China and one of only three global manufacturers to hold this certification for this critical local anesthetic.

  • Brochure About us

    Shandong Chenghui Shuangda Pharmaceutical Co., Ltd. specializes in R&D and production of APIs and advanced intermediates , CDMO/CRO/OEM, and Technology Transfer of Finished Formulations. With 23 years of production experience, the company operates 6 GMP-compliant workshops, achieving a monthly capacity of 100 tons to meet cGMP requirements. Currently, the factory has registered 21 APIs in NMPA, filed 4 US-DMFs, and applied for 9 CEPs, while successfully passing audits by MFDS, US FDA, and global customers.